Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer.

Oncotarget · 2017 · PMC5663592 · PMID 29137420

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

failed to reach statistical significancep>0.05actually significant

In conventional therapy groups, the NGR-PEG-LP-ZOL therapy group was slightly more effective than the ZOL or PEG-LP-ZOL therapy in inhibiting MVD, but the differences failed to reach statistical significance (p>0.05).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.